Apoptosis, proliferation, and sex steroid receptors in postmenopausal endometrium before and during HRT

Maturitas

Volumn 49, Issue 2, 2004, Pages 114-123

  Dahmoun, Marju ^a,b   Ödmark, Inga Stina ^b   Risberg, Björn ^c   Karlsson, Mats G ^d   Pavlenko, Tatjana ^a   Bäckström, Torbjörn ^b  

^a SUNDSVALL HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Apoptosis; Conjugated estrogen (CE); Postmenopausal endometrium

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ABDOMINAL PAIN; AMENORRHEA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; ENDOMETRIUM HYPERPLASIA; FEMALE; HEADACHE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MULTICENTER STUDY; QUANTITATIVE ANALYSIS; SPOTTING; THICKNESS; VAGINA BLEEDING;

APOPTOSIS; BIOPSY; CELL PROLIFERATION; ENDOMETRIUM; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; KI-67 ANTIGEN; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; NORETHINDRONE; POSTMENOPAUSE; PROSPECTIVE STUDIES; RECEPTORS, PROGESTERONE; REGRESSION ANALYSIS; SWEDEN; UTERINE HEMORRHAGE;

NETA;

EID: 4944228664     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.12.008     Document Type: Article

References (42)

1. Deligdisch L., Holinka C.F. Endometrial carcinoma: two diseases? Cancer Detect. Prev. 10(3-4):1987;237-246
2. Vidal J.D., Register T.C., Gupta M., Cline J.M. Estrogen replacement therapy induces telomerase RNA expression in the macaque endometrium. Fertil. Steril. 77(3):2002;601-608
3. Jeyarajah A., Oram D., Jacobs I. Molecular events in endometrial carcinogenesis. Int. J. Gynecol. Cancer. 6:1996;425-438
4. Miettinen M.M., Mustonen M.V., Poutanen M.H., Isomaa V.V., Vihko R.K. Human 17 beta-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem. J. 314(Pt 3):1996;839-845
5. Clarke C., Sutherland R. Progestin regulation of cellular proliferation. Endocrinol. Rev. 11:1990;266-272
6. Ferenzy A., Guralnic M. Endometrial microstructure: structure-function relationship throughout the menstrual cycle. Semin. Reprod. Endocrinol. 1(3):1983;205-219
7. Casper F.R. Regulation of estrogen/progestogen receptors in the endometrium. Int. J. Fertil. 41(1):1996;16-21
8. Hammond C.B. Menopause and hormone replacement therapy: an overview. Obstet. Gynecol. 87(2 (Suppl.)):1996;2S-15S
9. Odmark I.S., Jonsson B., Backstrom T. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with l7 beta-estradiol and norethindrone acetate. Am. J. Obstet. Gynecol. 184(6):2001;131-138
10. Korhonen M.O., Symons J.P., Hyde B.M., Rowan J.P., Wilborn W.H. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am. J. Obstet. Gynecol. 176(2):1997;377-380
11. Karlsson B., Granberg S., Wikland M., Ylostalo P., Torvid K., Marsal K., et al. Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicenter study [see comments]. Am. J. Obstet. Gynecol. 172(5):1995;1488-1494
12. Hickey M., Dwarte D., Fraser I.S. Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum. Reprod. 15(7):2000;1509-1514
13. Schwartzman R.A., Cidlowsky J.A. Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocrinol. Rev. 14(2):1993;133-151
14. Tenniswood M.P., Guenette R.S., Lakins J., Mooibroek M., Wong P., Welsh J.E. Active cell death in hormone dependent tissue. Cancer Metastasis Rev. 11:1992;197-220
15. Evans-Storms R.B., Cidlowsky J.A. Regulation of apoptosis by steroid hormones. J. Steroid Biochem. Mol. Biol. 53:1995;1-8
16. Rotello R.J., Lieberman R.C. Characterization of uterine epithelium apoptotic cell death kinetics and regulation by progesterone and RU 486. Am. J. Anat. 140:1992;449-456
17. Hopwood D., Levison D.A. Atrophy and apoptosis in the cyclical human endometrium. J. Pathol. 119:1975;159-166
18. Morsi H.M., Leers M.P., Jager W., Bjorklund V., Radespiel-Troger M., el Kabarity H., et al. The patterns of expression of an apoptosis-related CK18 neoepitope, the bcl-2 proto-oncogene, and the Ki-67 proliferation marker in normal, hyperplastic, and malignant endometrium. Int. J. Gynecol. Pathol. 19(2):2000;118-126
19. Morsi H.M., Leers M.P., Radespiel-Troger M., Bjorklund V., Kabarity H.E., Nap M., et al. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: an approach using multiparameter flow cytometry. Gynecol. Oncol. 77(1):2000;11-17
20. Henderson G.S., Brown K.A., Perkins S.L., Abbott T.M., Clayton F. bcl-2 is down-regulated in atypical endometrial hyperplasia and adenocarcinoma. Mod. Pathol. 9(4):1996;430-438
21. Kokawa K., Shikone T., Otani T., Nishiyama R., Ishii Y., Yagi S., et al. Apoptosis and the expression of Bax and Bc 1-2 in hyperplasia and adenocarcinoma of the uterine endometrium. Hum. Reprod. 16(10):2001;2211-2218
22. Johannisson E., Holinka C.F., Arrenbrecht S. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium. Int. J. Fertil. Womens Med. 42(Suppl. 2):1997;388-398
23. Brynhildsen J., Hammar M. Low dose transdermal estradiol/norethisterone acetate treatment over 2 years does not cause endometrial proliferation in postmenopausal women. Menopause. 9(2):2002;137-144
24. Darj E., Axelsson O., Nilsson G., Nilsson S., Risberg B. Ki-67 immunostaining of endometrial biopsies with special reference to hormone replacement therapy. Gynecol. Obstet. Invest. 39(2):1995;120-124
25. Cameron S.T., Critchley H.O., Glasier A.F., Williams A.R., Baird D.T. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women. Br. J. Obstet. Gynaecol. 104(10):1997;1184-1190
26. Gerdes J., Schwab U., Lemke H., Stein H. Production of the mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer. 31:1983;13-20
27. Moyer D.L., Felix J.C., Kurman R.J., Cuffie C.A. Micronized progesterone regulation of the endometrial glandular cycling pool. Int. J. Gynecol. Pathol. 20(4):2001;374-379
28. Harn H.J., Shen K.L., Yueh K.C., Ho L.I., Yu J.C., Chiu S.C., et al. Apoptosis occurs more frequently in intraductal carcinoma than in infiltrating duct carcinoma of human breast cancer and correlates with altered p53 expression: detected by terminal-deoxynucleotidyl-transferase-mediated dUTP-FITC nick end labelling (TUNEL). Histopathology. 31(6):1997;534-539
29. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wideranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-259
30. Dahmoun M., Boman K., Cajander S., Westin P., Backstrom T. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J. Am. Endocrinol. Metab. 84(5):1999;1737-1743
31. Hampton A.L., Salamonsen L.A. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation. J. Endocrinol. 141(1):1994;R1-R3
32. Salamonsen L.A., Zhang J., Brasted M. Leukocyte networks and human endometrial remodelling. J. Reprod. Immunol. 57(1-2):2002;95-108
33. Whitehead M.I., Townsend P.T., Pryse-Davies J., Ryder T., Lane G., Siddle N.C., et al. Effects of various types and dosages of progestogens on the postmenopausal endometrium. J. Reprod. Med. 27(8):1982;538-548
34. Ferenzy A. Regeneration of the human endometrium. New York: Masson Publications; 1980.
35. Faundes A., Alvarez F., Brache V., Cochon L. Endometrial thickness and oestradiol concentration in women with bleeding complaints during use of Norplant implants. Hum. Reprod. 13(1):1998;188-191
36. Gull B., Karlsson B., Milsom I., Wikland M., Granberg S. Transvaginal sonography of the endometrium in a representative sample of postmenopausal women. Ultrasound Obstet. Gynecol. 7(5):1996;322-327
37. Granberg S., Eurenius K., Lindgren R., Wilhelmsson L. The effects of oral estriol on the endometrium in postmenopausal women. Maturitas. 42(2):2002;149-156
38. Koshiyama M., Yoshida M., Takemura M., Yura Y., Matsushita K., Hayashi M., et al. Immunohistochemical analysis of distribution of estrogen receptors and progesterone receptors in the postmenopausal endometrium. Acta Obstet. Gynecol. Scand. 75(8):1996;702-706
39. Mourits M.J., Ten Hoor K.A., van der Zee A.G., Willemse P.H., de Vries E.G., Hollema H. The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium. J. Clin. Pathol. 55(7):2002;514-519
40. Saegusa M., Okayasu I. Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer. 83:1997;111-121
41. Deligdisch L. Hormonal pathology of the endometrium. Mod. Pathol. 13(3):2000;285-294
42. Mourits M.J., Hollema H., De Vries E.G., Ten Hoor K.A., Willemse P.H., Van Der Zee A.G. Apoptosis and apoptosis-associated parameters in relation to tamoxifen exposure in postmenopausal endometrium. Hum. Pathol. 33(3):2002;341-346